Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Shares Outstanding (Weighted Average) (2016 - 2025)

Wave Life Sciences (WVE) has disclosed Shares Outstanding (Weighted Average) for 11 consecutive years, with $168.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 21.96% year-over-year to $168.6 million, compared with a TTM value of $168.6 million through Dec 2025, up 21.96%, and an annual FY2025 reading of $168.6 million, up 21.96% over the prior year.
  • Shares Outstanding (Weighted Average) was $168.6 million for Q4 2025 at Wave Life Sciences, up from $164.8 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $168.6 million in Q4 2025 and bottomed at $49.1 million in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $105.5 million, with a median of $105.5 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Weighted Average) soared 85.17% in 2022, then grew 21.96% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $51.8 million in 2021, then soared by 52.16% to $78.9 million in 2022, then surged by 34.55% to $106.1 million in 2023, then surged by 30.33% to $138.3 million in 2024, then increased by 21.96% to $168.6 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for WVE at $168.6 million in Q4 2025, $164.8 million in Q3 2025, and $164.0 million in Q2 2025.